Severe osteoporosis due to systemic mast cell disease: Successful treatment with interferon alpha-2b

British Journal of Rheumatology

Volumn 35, Issue 9, 1996, Pages 898-900

  Lehmann, T ^a   Beyeler, C ^a   Lammle B ^a   Hunziker, T ^b   Vock, P ^a   Olah, A J ^a   Dahinden, C ^a   Gerber, N J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Klinik und Poliklinik fur Dermatologie   (Switzerland)

Author keywords

Interferon alpha; Osteoporosis; Systemic mast cell disease

Indexed keywords

ALPHA2B INTERFERON; CLODRONIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE MARROW; BONE MINERAL; CASE REPORT; DRUG EFFICACY; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MAST CELL; OSTEOPOROSIS; PRIORITY JOURNAL; TRABECULAR BONE; URTICARIA PIGMENTOSA; VERTEBRA; VERTEBRA FRACTURE;

EID: 0029796701     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.9.898     Document Type: Article

References (23)

1. Webb TA, Li CY, Yam LT. Systemic mast cell disease: a clinical and hematopathological study of 26 cases. Cancer 1982;49:927-38.
2. Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-86.
3. Tharp MD. Southwestern Internal Medicine Conference: the spectrum of mastocytosis. Am J Med Sci 1985; 289:119-32.
4. De Gennes C, Kuntz D, De Vernejoul MC. Bone mastocytosis: a report of nine cases with a bone histomorphometric study. Clin Orthop 1992;279: 281-91.
5. Lidor C, Frisch B, Gazit D, Gepstein R, Hallel T, Mekori YA. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res 1990; 5:871-6.
6. Lidor C, Hallel T, Oren VO. Migratory multiple bone involvement in a patient with systemic mastocytosis. Clin Nucl Med 1990;15:640-3.
7. Chines A, Pacifici R, Avioli LA, Korenblat PE, Teitelbaum SL. Systemic mastocytosis and osteoporosis. Osteoporos Int 1993;3(suppl. 1P):147-9.
8. Floman Y, Amir G. Systemic mastocytosis presenting with severe spinal osteopenia and multiple compression fractures. J Spinal Disord 1991;4:369-73.
9. Andrew SM, Freemont AJ. Skeletal mastocytosis. J Clin Pathol 1993;46:1033-5.
10. Harvey JA, Anderson HC, Borek D, Morris D, Lukert BP. Osteoporosis associated with mastocytosis confined to bone: report of two cases. Bone 1989;10:237-41.
11. Schoenaers P, DeClerck LS, Timmermanns U, Stevens WJ. Systemic mastocytosis, an unusual cause of osteoporosis. Clin Rheumatol 1987;6:458-62.
12. Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 1991;96:55S-59S.
13. Camus JP, Prier A, Lièvre JA, Stephan JC, Laveant C. L'Ostéoporose mastocytaire. Rev Rhum Ed Fr 1979; 46:29-35.
14. Cundy T, Beneton MNC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.
15. Conrad ME, Carpenter JT, Toddn JN, Murat TM. Mithramycin in the treatment of systemic mastocytosis. Ann Intern Med 1975;83:659-60.
16. Kluin-Nelemans HC, Jansen JH, Breukelman H et al. Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med 1992;326:619-23.
17. Austen KF. Systemic mastocytosis. N Engl J Med 1992;326:639-40.
18. Kalender WA, Felsenberg D, Louis O et al. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol 1989;9:75-80.
19. Schenk RK, Olah AJ. Histomorphometrie. In: Kuhlencordt F, Bartelheimer H, eds. Handbuch der Inneren Medizin VI/1A. Springer, 1980:438-94.
20. Metcalfe D. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96:2S-4S.
21. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann Intern Med 1991;114:532-8.
22. Delaporte E, Pierard E, Wothers BG et al. Interferon-α in combination with corticosteroids improves systemic mast cell diseae. Br J Dermatol 1995;132:479-94.
23. Czarnetzki BM, Algermissen B, Jeep S et al. Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30:500-1.